Herbs (Global Traditional) · Amazonian
Dragon's Blood (Croton lechleri) (Croton lechleri)
Moderate Evidencebotanical
Hermetica Superfood Encyclopedia
Dragon's blood from Croton lechleri contains taspine and proanthocyanidins that form protective barriers on damaged tissue. The FDA-approved extract crofelemer blocks chloride channels in intestinal epithelium, reducing secretory diarrhea.
Dragon's Blood is a dark red latex resin obtained from the Croton lechleri tree native to the Amazon rainforest in Peru, Ecuador, Colombia, and Bolivia. The resin is harvested by making incisions in the tree trunk, allowing the sap to ooze out and dry into a protective barrier that contains over 90% proanthocyanidins by dry weight.
The FDA approved crofelemer (SP-303), a purified proanthocyanidin from Dragon's Blood, in 2013 based on two pivotal Phase 3 RCTs showing significant reduction in HIV-associated diarrhea at 125mg twice daily. One in vitro study (PMID: 14598201) demonstrated immune-modulating effects through complement pathway inhibition, though most evidence remains limited to laboratory and animal studies.
Clinically studied dosage: Crofelemer (standardized extract) 125mg orally twice daily for HIV-associated diarrhea. Traditional topical use involves undiluted sap applied directly to wounds. No established safe dosage range for crude resin or non-standardized extracts. Consult a healthcare provider before starting any new supplement.
Dragon's Blood is not consumed as a food/nutritional source but as a medicinal latex resin; therefore, standard macronutrient profiling (carbohydrates, fats, protein, fiber) is not applicable in conventional dietary terms. Its significance lies entirely in its bioactive phytochemical composition: **Primary Bioactive Compounds:** • **Taspine** (alkaloid): ~0.5–1.0% of dried latex; major wound-healing compound acting as an anti-inflammatory and cell-migration stimulant (promotes fibroblast proliferation) • **Proanthocyanidins (SP-303 / Crofelemer)**: Oligomeric proanthocyanidins constitute ~60–90% of the dry weight of the latex; the purified extract (crofelemer) is the active pharmaceutical ingredient in Mytesi® (FDA-approved); acts as a dual inhibitor of CFTR chloride channels and calcium-activated chloride channels (CaCC) in intestinal epithelium • **Catechin and epicatechin**: Present at approximately 1–3% of dry latex; contribute to antioxidant and antimicrobial activity • **Dimethylcedrusine** (lignan): ~0.01–0.05%; contributes to wound-healing properties • **3',4-O-dimethylcedrusine**: Lignan with documented in vitro cell proliferation activity **Other Phenolic Compounds:** • Gallocatechin, epigallocatechin: trace to minor concentrations • Proanthocyanidin oligomers (dimers through decamers): bulk of polyphenol fraction • Total polyphenol content: estimated at 70–90% of dried resin by weight (exceptionally high compared to most botanical preparations) **Terpenoid Fraction (minor):** • Hardwickiic acid and related clerodane diterpenes: <1% of dry latex **Mineral Content:** • Not a significant source of dietary minerals; trace amounts of calcium, potassium, magnesium, and iron have been detected in crude latex but are not nutritionally relevant at typical dosing (1–5 mL per day traditionally, or 125 mg crofelemer tablet pharmaceutically) **Vitamins:** No significant vitamin content documented. **Bioavailability Notes:** • Crofelemer (SP-303) has intentionally minimal systemic absorption (<0.5% oral bioavailability); it acts locally on the GI lumen, which is pharmacologically advantageous for its antisecretory mechanism and contributes to its favorable safety profile • Taspine is absorbed systemically when applied topically to wounds, facilitating local anti-inflammatory and cell-migration effects • The high molecular weight of oligomeric proanthocyanidins (MW ~1,500–3,000 Da) limits systemic absorption; most activity is localized to the gastrointestinal tract or site of topical application • Monomeric catechins (catechin, epicatechin) have moderate oral bioavailability (~5–15%), similar to dietary sources like tea and cocoa • Traditional preparation (diluting drops of latex in water) may influence proanthocyanidin aggregation state and therefore bioaccessibility
Crofelemer blocks cystic fibrosis transmembrane conductance regulator (CFTR) and calcium-activated chloride channels in intestinal epithelial cells, reducing fluid secretion. Taspine and proanthocyanidins precipitate with tissue proteins to form protective films over wounds. The phenolic compounds exhibit antimicrobial activity against gram-positive bacteria through cell wall disruption.
Two Phase 3 randomized controlled trials (n=380 and n=236) demonstrated crofelemer's efficacy for HIV-associated diarrhea, leading to FDA approval. The extract significantly reduced loose stools and improved quality of life scores compared to placebo. Wound healing evidence relies primarily on traditional use and in vitro antimicrobial studies, with limited human clinical data. Additional studies show modest anti-inflammatory effects, but sample sizes remain small.
Dragon's blood extract is generally well-tolerated with mild gastrointestinal side effects reported in clinical trials. No significant drug interactions have been documented, though theoretical concerns exist with medications requiring intestinal absorption due to barrier formation. Safety during pregnancy and breastfeeding is unknown due to insufficient data. Individuals with bleeding disorders should consult healthcare providers before use due to potential wound healing effects.
